Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.759
-0.019 (-2.46%)
At close: Nov 20, 2024, 4:00 PM
0.737
-0.022 (-2.87%)
Pre-market: Nov 21, 2024, 6:33 AM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $1.25 million as of November 21, 2024. Its market cap has decreased by -67.00% in one year.
Market Cap
1.25M
Enterprise Value
-5.29M
1-Year Change
-67.00%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.67M to $1.25M, a decrease of -98.62%. That is a compound annual growth rate of -65.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.28M | -59.46% |
| Dec 29, 2023 | 3.15M | -29.53% |
| Dec 30, 2022 | 4.47M | -93.31% |
| Dec 31, 2021 | 66.84M | -28.41% |
| Dec 31, 2020 | 93.37M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tivic Health Systems | 1.56M |
| GlucoTrack | 1.41M |
| ZyVersa Therapeutics | 1.38M |
| Entero Therapeutics | 1.37M |
| Altamira Therapeutics | 1.36M |
| China SXT Pharmaceuticals | 1.33M |
| Tenon Medical | 1.22M |
| Catheter Precision | 1.19M |